How is GazetAI different from Apple News or Google News?

Other apps show you everything. GazetAI shows you only what matters — and analyzes each story across 19 dimensions before you even open it.

Why can't I just read the news myself?

The world publishes 2+ million articles every day. Reading them all at 250 words per minute would take 130 years — without sleeping. The average person sees about 0.0005% of what's published. GazetAI's AI reads everything and surfaces only the stories that actually matter to you.

Do I need to read the full article?

No. The AI summary and analysis dashboard give you the full picture in under a minute. Open the original only if you want to.

What does the free trial include?

Full access to 3 categories for 7 days. No charge unless you continue.

Can I cancel anytime?

Yes. Cancel from the app or your billing portal. You keep access until the end of your billing period.

What languages are supported?

9 languages: English, Spanish, French, German, Portuguese, Arabic, Japanese, Chinese, Russian. Every analysis is fully translated.

Where do the news come from?

We aggregate from 50,000+ professional sources, then enrich every article with our AI pipeline.

← All Health news

Open in app

Centre directs tighter surveillance of GLP-1 drug promotion

2 min read

The government told state and union territory drug regulators to strengthen oversight of GLP-1 weight-loss drugs after concerns about surrogate advertising and misleading awareness campaigns. Minister of State for Health Anupriya Patel said the CDSCO has approved GLP-1 receptor agonists only for type 2 diabetes and chronic weight management in adults with specified conditions, and they may be dispensed only on endocrinologist or internal medicine specialist prescription. CDSCO advisories on March 10 and March 27, 2026, barred surrogate promotion, ordered stricter supply-chain monitoring, and asked states to act against diversion and non-compliant advertisements under existing drug laws.

CDSCO barred surrogate ads and ordered stricter GLP-1 supply monitoring.

The full analysis

19 dimensions on this story — world impact, market read, and what happens next.

Full ContextLocked
Affected SectorsLocked
Stock ImpactLocked
Economic IndicatorLocked
Investor RelevanceLocked
Professional RelevanceLocked
Watch PointsLocked
Probability of ChangeLocked
Debate PointsLocked
Follow-up QuestionsLocked
Pros & ConsLocked

Start your 7-day free trial